BGP Company Profiles - Data/BGP Table of Biggest For-Profit Companies
< BGP Company Profiles - Data(Redirected from BGP Table of Biggest For-Profit Companies)
Jump to navigation
Jump to search
| 2006 Revenue ($m) | Headquarters | Primary Outputs | Instances of Commons-based approaches | |
| Amgen | 14268
|
Thousand Oaks, California | ten approved drugs for 15 conditions, 23 agents are being tested earlier in the approval pipeline | Amgen - marketing and R&D collaborations with (Powell pp. 72): ARRIS, Envirogen, Glycomex, Guilford, Interneuron, Regeneron, and Zynaxis. these companies develop the product that Amgen later produces and markets. Perhaps there are instances of commons-like sharing here. Further investigation needed |
| Genentech
|
9284
|
South San Francisco
|
synthetic human insulin - their first famous product, many others produced using the Boyer-Cohen rDNA process | ? |
| Genzyme
|
3187
|
Cambridge, Massachusetts
|
Cerezyme (treats Gaucher's disease) accounts for 30% of company's revenue | ? |
| Gilead Sciences
|
3026
|
Foster City, California | 11 commercial products
|
? |
| Biogen Idec
|
2683
|
Cambridge, Massachusetts
|
Treatments for Crohn's disease, non-Hodgkin's lymphoma, and multiple sclerosis | Biogen outsources analyzing clinical trial data to other research labs (Powell pp. 72). Perhaps some of these exhibit commons-like behavior |
| Cephalon
|
1764
|
Frazer, Pennsylvania | Specializes in treating neurodegenerative diseases | ? |
| MedImmune
|
1277
|
Gaithersburg, Maryland | Only major drug prevents respiratory diseases in infants | ? |
| Celgene
|
899
|
Summit, New Jersey
|
treatments for erythema nodosum leprosum ("ENL") and multiple myeloma | ? |
| Abraxis BioScience
|
766
|
Los Angeles, California
|
uses patented nanoparticle technology to produce products for metastatic breast cancer | ? |
| ImClone Systems
|
678
|
New York, New York
|
acquired by Eli Lilly, tried to produce Erbitux for Colorectal Cancer, but failed to win FDA approval | ? |
IP_Profile_of_Biggest_for-profit_companies_in_BGP
| Company | Revenue in 2006 (USD millions) | R&D in 2006 (USD millions) | Net income/ (loss) in 2006 (USD millions) | Employees in 2006 | % of US GDP |
| Amgen | 14268 | 3366 | 2950 | 20100 | 0.00108 |
| Genentech | 9284 | 1773 | 2113 | 10533 | 0.00070 |